Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

Nonalcoholic fatty liver disease (NAFLD) is a group of obesity-associated pathological changes characterized by abnormal accumulation of lipids in cells of the liver parenchyma. NAFLD and associated conditions, namely insulin resistance and type II diabetes mellitus (DM2), as well as the possible ri...

Full description

Bibliographic Details
Main Authors: Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Format: Article
Language:English
Published: Endocrinology Research Centre 2018-02-01
Series:Сахарный диабет
Subjects:
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
farnesoid x
Online Access:https://dia-endojournals.ru/dia/article/viewFile/9374/7120

Internet

https://dia-endojournals.ru/dia/article/viewFile/9374/7120

Similar Items